Type 2 diabetes mellitus is not a single disease but a genetically heteroge
nous group of metabolic disorders sharing glucose intolerance. The precise
underlying biochemical defects are unknown and almost certainly include imp
airments of both insulin secretion and action. The rapidly increasing preva
lence of T2D world wide makes it a major cause of morbidity and mortality.
Understanding the genetic aetiology of T2D will facilitate its diagnosis, t
reatment and prevention. The results of linkage and association studies to
date demonstrate that, as with other common diseases, multiple genes are in
volved in the susceptibility to T2D, each making a modest contribution to t
he overall risk. The completion of the draft human genome sequence and a br
ace of novel tools for genomic analysis promise to accelerate progress towa
rds a more complete molecular description of T2D.